These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2849237)

  • 1. Intertypic genomic rearrangements of poliovirus strains in vaccinees.
    Cammack N; Phillips A; Dunn G; Patel V; Minor PD
    Virology; 1988 Dec; 167(2):507-14. PubMed ID: 2849237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.
    Cuervo NS; Guillot S; Romanenkova N; Combiescu M; Aubert-Combiescu A; Seghier M; Caro V; Crainic R; Delpeyroux F
    J Virol; 2001 Jul; 75(13):5740-51. PubMed ID: 11390576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].
    Kutitova OK; Lipskaia GIu; Maslova SV; Agol VI
    Mol Gen Mikrobiol Virusol; 1989 Nov; (11):14-20. PubMed ID: 2560812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral poliovirus vaccine in the United States: molecular characterization of Sabin type 3 after replication in the gut of vaccinees.
    Tatem JM; Weeks-Levy C; Mento SJ; DiMichele SJ; Georgiu A; Waterfield WF; Sheip B; Costalas C; Davies T; Ritchey MB
    J Med Virol; 1991 Oct; 35(2):101-9. PubMed ID: 1662701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees.
    Karakasiliotis I; Markoulatos P; Katsorchis T
    Mol Cell Probes; 2004 Apr; 18(2):103-9. PubMed ID: 15051119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee.
    Minor PD; John A; Ferguson M; Icenogle JP
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():693-706. PubMed ID: 2420925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant.
    Dedepsidis E; Pliaka V; Kyriakopoulou Z; Brakoulias C; Levidiotou-Stefanou S; Pratti A; Mamuris Z; Markoulatos P
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):343-51. PubMed ID: 18328076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary structure of the crossover region in the genome of two intertype poliovirus recombinant].
    Romanova LI; Viktorova EG; Tol'skaia EA; Kolesnikova MS; Guseva EA
    Bioorg Khim; 1985 Dec; 11(12):1685-7. PubMed ID: 3002394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases.
    Lipskaya GY; Muzychenko AR; Kutitova OK; Maslova SV; Equestre M; Drozdov SG; Bercoff RP; Agol VI
    J Med Virol; 1991 Dec; 35(4):290-6. PubMed ID: 1666406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
    Friedrich F; Da-Silva EF; Schatzmayr HG
    Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
    Blomqvist S; Bruu AL; Stenvik M; Hovi T
    J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
    Georgopoulou A; Markoulatos P
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1.
    Blomqvist S; Savolainen-Kopra C; Paananen A; El Bassioni L; El Maamoon Nasr EM; Firstova L; Zamiatina N; Kutateladze T; Roivainen M
    Virus Res; 2010 Aug; 151(2):246-51. PubMed ID: 20493912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic recombination in vaccine poliovirus: comparative study in strains excreted in course of vaccination by oral poliovirus vaccine and circulating strains].
    Haddad-Boubaker S; Ould-Mohamed-Abdallah MV; Ben-Yahia A; Triki H
    Pathol Biol (Paris); 2010 Dec; 58(6):420-5. PubMed ID: 19299091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine derived bi- and multi-recombinant Sabin strains.
    Paximadi E; Karakasiliotis I; Bolanaki E; Krikelis A; Markoulatos P
    Virus Genes; 2007 Dec; 35(3):541-8. PubMed ID: 17680217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Sabin environmental isolates in Greece and Cyprus.
    Paximadi E; Karakasiliotis I; Papaventsis D; Papageorgiou G; Markoulatos P
    J Appl Microbiol; 2008 Apr; 104(4):1153-62. PubMed ID: 18031522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
    Friedrich F
    Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of clinical isolations of oral poliovirus vaccine strains between 2000 and 2005 in southern Taiwan.
    Chi CY; Tseng FC; Liu DP; Chang YW; Wu HC; Huang YF; Hwang KP; Hsu YW; Wang SM; Liu CC; Wu HS; Yang JY; Yang CF; Wang JR; Su IJ
    J Clin Virol; 2009 Jun; 45(2):129-34. PubMed ID: 19394265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.